Core Insights - WINFARM reported a strong improvement in its 2025 full-year results, with significant growth in revenue and EBITDA, indicating a positive trajectory for the company [1][4][11] Financial Performance - The consolidated revenue for 2025 reached €146.5 million, marking a 6.1% increase from €138.0 million in 2024 [3][4] - The gross margin improved to 34.4% of revenue, up from 33.5% in 2024, reflecting effective pricing strategies [3][11] - EBITDA surged to €5.3 million, a 3.9 times increase compared to €1.4 million in 2024, with the EBITDA margin rising by 2.6 percentage points to 3.6% [3][13] - The net loss for 2025 decreased to €0.8 million from €3.7 million in 2024, indicating a recovery in financial performance [3][14] Business Segments - The Farming Supplies segment, which constitutes 86% of total revenue, generated €127.2 million, a 4.5% increase, driven by strong sales in the "Hygiene" and "Animal Nutrition" product families [5][4] - The Farming Production segment saw a revenue increase of 19% to €16.6 million, with Asia contributing nearly 40% of this revenue and experiencing a growth rate of 47.3% compared to 2024 [9] - Other activities, including Farming Advisory and Farming Innovation, also reported growth, supported by new sales initiatives [10] Cash Flow and Debt Management - The company generated cash flow of €1.4 million in 2025, a significant turnaround from a negative cash flow of €5.4 million in 2024 [6][17] - WINFARM reduced its net financial debt by €7 million, bringing it down to €29.2 million by the end of 2025 [17] Strategic Outlook - For 2026, WINFARM plans to continue its sales initiatives, particularly focusing on the 30th anniversary of the VITAL brand, which has shown strong growth in key markets [18] - The company aims to maintain operational and financial discipline, which is expected to lead to further increases in EBITDA and continued debt reduction [19]

Core Insights - WINFARM reported a significant increase in EBITDA, cash generation, and debt reduction for H1 2025, indicating a positive outlook for continued growth and improved operating profitability [1][15]. Financial Performance - Revenue for H1 2025 reached €74.5 million, a 6.5% increase from €69.98 million in H1 2024 [3][4]. - Gross margin improved to 33.6% of revenue, up from 32.4% in H1 2024, reflecting effective sales initiatives [3][9]. - EBITDA surged to €2.43 million, compared to €196,000 in H1 2024, marking a substantial increase of €2.24 million [3][10]. - The Group's net loss was reduced to €0.65 million from €2.70 million in the same period last year [3][12]. Business Segments - The Farming Supplies division, which constitutes 87% of total revenue, generated €65.1 million, a 3.9% increase [5]. - The Farming Production business saw a remarkable 30% revenue growth, reaching €8.2 million, attributed to a new production line [5]. - The VITAL brand experienced a growth of 4.7%, while the EQUIDEOS brand grew by 7.4% [6]. - The APAC market, a new focus area, reported over 40% revenue growth [7]. Cost Management and Cash Flow - Personnel expenses decreased by 1.0%, and external expenses fell by 1.9%, contributing to improved profitability [3][10]. - Cash flow from operations was €2.4 million, a significant increase of €2.5 million compared to H1 2024 [13]. - Working capital requirements (WCR) decreased by €300,000, primarily due to a €1.5 million reduction in inventories [13]. Debt and Equity - Financial debt decreased from €35.5 million at the end of 2024 to €32.3 million by June 2025, indicating ongoing deleveraging efforts [14]. - Shareholders' equity stood at €15.5 million, down from €16.2 million a year earlier [13]. Future Outlook - WINFARM anticipates continued profitable growth in 2025, driven by improved operating profitability and gradual debt reduction [15][16]. - The company aims to focus on higher value-added activities and maintain strict investment discipline [15][16].